Home » Topics » Regulatory » Patents

Patents
RSS

Novel immunomodulating agents from Gruenenthal

July 31, 1997

Cell adhesion inhibitors disclosed by Hoechst

July 31, 1997

Chiroscience reports PDE/TNF inhibitors

July 30, 1997

Inhibitors of cyclin-dependent protein kinases disclosed by CNRS researchers

July 30, 1997

Human SMC migration factor and modulators thereof described by SKB and HGS

July 30, 1997

GnRH conjugate vaccines prepared at Merck & Co.

July 30, 1997

RPR prepares novel transfection agents

July 29, 1997

Merck KGaA discloses novel ET antagonists

July 29, 1997

U.K. university researchers develop new agents for AD

July 25, 1997

Piperidone and glutarimide neurokinin antagonists developed at Pfizer

July 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...